Join the club for FREE to access the whole archive and other member benefits.

Robin Carhart-Harris

Head of Imperial Psychedelic Research Group at Imperial College London.

Robin Carhart-Harris is a psychologist and neuroscientist at Imperial College London who leads a Psychedelic drug research programme there.

Robin Carhart-Harris successfully coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years.
After being awarded an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, Carhart-Harris moved to Imperial College London to continue his fMRI research with the classic psychedelic drug psilocybin (magic mushrooms). Over the last four years Carhart-Harris & Nutt have built up a programme of research with psychedelics that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA and soon an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression.

Visit website: https://www.imperial.ac.uk/people/r.carhart-harris

carhart-harris-robin-19112542

RCarhartHarris

See also: Academia Imperial College London (ICL) - Public research university with an international reputation for excellence in teaching and research